Paul Pappademos, MD
Adult Reconstructive Orthopaedic Surgery · Wichita, KSNPI 1013984699
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (38.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Brixton Biosciences, Inc. at 51.9% of the total.
Across 37 payments — averaging $120.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Brixton Biosciences, Inc.$2K
- Stryker$2K
- Johnson & Johnson$115
- Onkos Surgical, Inc.$95
- Pacira Therapeutics, Inc.$34
- Vertex$32
- plus $143 from 7 others
What the payments were for
- Speaking & faculty fees$1,50034%
- Travel & lodging$1,72639%
- Food & beverage$1,22728%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Brixton Biosciences, Inc. | 2 | $2,310 |
| Stryker | 18 | $1,725 |
| Johnson & Johnson | 4 | $115 |
| Onkos Surgical, Inc. | 1 | $95 |
| Pacira Therapeutics, Inc. | 2 | $34 |
| Vertex | 1 | $32 |
| Ferring Pharmaceuticals Inc. | 2 | $31 |
| Amgen | 2 | $24 |
| Convatec Inc. | 1 | $22 |
| Encore Medical, LP | 1 | $20 |
| Pfizer | 1 | $17 |
| Heraeus Medical, LLC. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neural Ice$2,310
- MAKO$1,169
How this compares
Too few adult reconstructive orthopaedic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 568 | $1,335 |
| Amoxicillin | 23 | $11 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Wichita
- Tarun BhargavaWichita$534K
- Benjamin YoungWichita$4K
- James JosephWichita$144
- Kelly HendricksOverland Park$250K
- Jonathon SalavaTopeka$52K
- Andrew PalmisanoOverland Park$40K
- Matthew de RuyterKansas City$23K
- Michael PerryOverland Park$14K
- Andrew MurthaKansas City$9K
- Scott WingerterLeawood$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.